(Q54601373)

1 June 2018

title

A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. (English)

1 reference

1 June 2018

0 references

Kirchheiner J

1

1 reference

1 June 2018

Nickchen K

2

1 reference

1 June 2018

Sasse J

3

1 reference

1 June 2018

Bauer M

4

1 reference

1 June 2018

Roots I

5

1 reference

1 June 2018

Brockmöller J

6

1 reference

1 June 2018

publication date

9 May 2006

1 reference

1 June 2018

The Pharmacogenomics Journal

published in

1 reference

1 June 2018

volume

7

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

48-55

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500398

exact match

0 references

cites work

The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVES

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Effect of antidepressants on striatal and accumbens extracellular dopamine levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Statistics notes. The odds ratio

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

The multifactorial presentation of depression in acute care

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Corelease of dopamine and serotonin from striatal dopamine terminals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Dopaminergic mechanism of antidepressant action in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Timing of Onset of Antidepressant Response With Fluoxetine Treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Placebo-controlled continuation treatment with mirtazapine: acute pattern of response predicts relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Family-based association study between bipolar disorder and DRD2, DRD4, DAT, and SERT in Sardinia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Possible locus for bipolar disorder near the dopamine transporter on chromosome 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Serotonin transporter: gene, genetic disorders, and pharmacogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Anxiety- and novelty seeking-related personality traits and serotonin transporter gene polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500398

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500398

1 reference

1 June 2018

Dimensions Publication ID

1000329854

0 references

1 reference

1 June 2018